1-3 of 3
Deepak Parashar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibiting FOXM1 Sensitizes Myeloma Cells to BCL2 Inhibitor Venetoclax By Repressing MYC Pathway

Vivian Zhou, Luke Moat, Manya Yu, Deepak Parashar, Abdul Shour, Liang Zhang, Terrie Kitchner, Sanjay Shukla, Song Guo, Gene Ananiev, Benita S. Katzenellenbogen, John Katzenellenbogen, Adedayo Onitilo, Siegfried Janz, Zhi Wen
Journal: Blood
Blood (2023) 142 (Supplement 1): 1950.
https://doi.org/10.1182/blood-2023-180268
Published: 2023
Journal Articles

Transgenic Mouse Model for Translational Immunotherapy Studies on Multiple Myeloma

Manya Yu, Vivian Zhou, Michael D Pisano, Deepak Parashar, Xing Cui, Siegfried Janz
Journal: Blood
Blood (2023) 142 (Supplement 1): 6565.
https://doi.org/10.1182/blood-2023-173410
Published: 2023
Journal Articles

A Genomic Signature Predicting Venetoclax Treatment Response in AML Identified By Protein Network Mapping and Validated By Ex Vivo Drug Sensitivity Testing: A Beat AML Project Study

Leylah Drusbosky, PhD, Taher Abbasi, Shireen Vali, PhD, Saumya Radhakrishnan, Neeraj Kumar Singh, Shahabuddin Usmani, Deepak Parashar, Robinson Vidva, Brian J. Druker, MD, Cristina E. Tognon, Pierrette Lo, MS, Jeffrey W. Tyner, Christopher R. Cogle, MD
Journal: Blood
Blood (2016) 128 (22): 1713.
https://doi.org/10.1182/blood.V128.22.1713.1713
Published: 2016